MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with C

Capecitabine

Capecitabine 150mg tablets

Incompatible

Stability notes for Capecitabine 150mg tablets

Cytotoxic medicine. Not recommended due to handler risk.

Suppliers

Capecitabine 150mg tablets (Accord-UK Ltd)
Capecitabine 150mg tablets (Amarox Ltd)
Capecitabine 150mg tablets (Glenmark Pharmaceuticals Europe Ltd)

Capecitabine 300mg tablets

Incompatible

Stability notes for Capecitabine 300mg tablets

Cytotoxic medicine. Not recommended due to handler risk.

Supplier

Capecitabine 300mg tablets (Accord-UK Ltd)

Capecitabine 500mg tablets

Incompatible

Stability notes for Capecitabine 500mg tablets

Cytotoxic medicine. Not recommended due to handler risk.

Suppliers (4) of Capecitabine 500mg tablets
Capecitabine 500mg tablets (Accord-UK Ltd)
Capecitabine 500mg tablets (Amarox Ltd)
Capecitabine 500mg tablets (Dr Reddy's Laboratories (UK) Ltd)
Capecitabine 500mg tablets (Glenmark Pharmaceuticals Europe Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.